Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
UBS
Fish and Richardson
Johnson and Johnson
Cipla
Baxter
Chinese Patent Office
Argus Health
Cerilliant
Merck

Generated: October 18, 2017

DrugPatentWatch Database Preview

NEBUPENT Drug Profile

« Back to Dashboard

What is the patent landscape for Nebupent, and what generic Nebupent alternatives are available?

Nebupent is a drug marketed by Fresenius Kabi Usa and is included in one NDA.

The generic ingredient in NEBUPENT is pentamidine isethionate. There are thirteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the pentamidine isethionate profile page.

Summary for Tradename: NEBUPENT

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list112
Clinical Trials: see list1
Patent Applications: see list795
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NEBUPENT at DailyMed

Pharmacology for Tradename: NEBUPENT

Drug ClassAntiprotozoal
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa
NEBUPENT
pentamidine isethionate
FOR SOLUTION;INHALATION019887-001Jun 15, 1989RXYesYes► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
NEBUPENT
pentamidine isethionate
FOR SOLUTION;INHALATION019887-002Mar 22, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Accenture
Boehringer Ingelheim
Mallinckrodt
Federal Trade Commission
Fuji
McKesson
Baxter
Argus Health
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot